Gilead

I

Imogene

Administrator
Dear Community,

I hate to bring the news that the appeal for the Gilead Sciences' Aztreonam Lysine for Inhalation (AZLI) was not approved by the FDA.

Gilead had appealed the original decision not to approve the drug.

With the approval of this drug would have come the FDA approval for the e-Flow nebulizer also.

We received this news with a personal call from Gilead thanking all the members of our site who have supported them through this process.

Gilead promises to continue their Expanded Access Program and is committed to working with the FDA on the additional trials needed.

Sadly,

Jeanne
 
I

Imogene

Administrator
Dear Community,

I hate to bring the news that the appeal for the Gilead Sciences' Aztreonam Lysine for Inhalation (AZLI) was not approved by the FDA.

Gilead had appealed the original decision not to approve the drug.

With the approval of this drug would have come the FDA approval for the e-Flow nebulizer also.

We received this news with a personal call from Gilead thanking all the members of our site who have supported them through this process.

Gilead promises to continue their Expanded Access Program and is committed to working with the FDA on the additional trials needed.

Sadly,

Jeanne
 
I

Imogene

Administrator
Dear Community,

I hate to bring the news that the appeal for the Gilead Sciences' Aztreonam Lysine for Inhalation (AZLI) was not approved by the FDA.

Gilead had appealed the original decision not to approve the drug.

With the approval of this drug would have come the FDA approval for the e-Flow nebulizer also.

We received this news with a personal call from Gilead thanking all the members of our site who have supported them through this process.

Gilead promises to continue their Expanded Access Program and is committed to working with the FDA on the additional trials needed.

Sadly,

Jeanne
 
I

Imogene

Administrator
Dear Community,

I hate to bring the news that the appeal for the Gilead Sciences' Aztreonam Lysine for Inhalation (AZLI) was not approved by the FDA.

Gilead had appealed the original decision not to approve the drug.

With the approval of this drug would have come the FDA approval for the e-Flow nebulizer also.

We received this news with a personal call from Gilead thanking all the members of our site who have supported them through this process.

Gilead promises to continue their Expanded Access Program and is committed to working with the FDA on the additional trials needed.

Sadly,

Jeanne
 
I

Imogene

Administrator
Dear Community,
<br />
<br />I hate to bring the news that the appeal for the Gilead Sciences' Aztreonam Lysine for Inhalation (AZLI) was not approved by the FDA.
<br />
<br />Gilead had appealed the original decision not to approve the drug.
<br />
<br />With the approval of this drug would have come the FDA approval for the e-Flow nebulizer also.
<br />
<br />We received this news with a personal call from Gilead thanking all the members of our site who have supported them through this process.
<br />
<br />Gilead promises to continue their Expanded Access Program and is committed to working with the FDA on the additional trials needed.
<br />
<br />Sadly,
<br />
<br />Jeanne
 
M

MCGrad2006

Guest
This is kind of a shock to me! The last I heard (last week) was that they were still trying to use some of the data they had collected from prior trials. Do they know if there will DEF be a new trial? I heard that there was another new drug that may be even more promising.

Bummer <img src="i/expressions/face-icon-small-sad.gif" border="0">
 
M

MCGrad2006

Guest
This is kind of a shock to me! The last I heard (last week) was that they were still trying to use some of the data they had collected from prior trials. Do they know if there will DEF be a new trial? I heard that there was another new drug that may be even more promising.

Bummer <img src="i/expressions/face-icon-small-sad.gif" border="0">
 
M

MCGrad2006

Guest
This is kind of a shock to me! The last I heard (last week) was that they were still trying to use some of the data they had collected from prior trials. Do they know if there will DEF be a new trial? I heard that there was another new drug that may be even more promising.

Bummer <img src="i/expressions/face-icon-small-sad.gif" border="0">
 
M

MCGrad2006

Guest
This is kind of a shock to me! The last I heard (last week) was that they were still trying to use some of the data they had collected from prior trials. Do they know if there will DEF be a new trial? I heard that there was another new drug that may be even more promising.

Bummer <img src="i/expressions/face-icon-small-sad.gif" border="0">
 
M

MCGrad2006

Guest
This is kind of a shock to me! The last I heard (last week) was that they were still trying to use some of the data they had collected from prior trials. Do they know if there will DEF be a new trial? I heard that there was another new drug that may be even more promising.
<br />
<br />Bummer <img src="i/expressions/face-icon-small-sad.gif" border="0">
 
You must log in or register to reply here.
Top